Merck & Co., Inc. (NYSE:MRK) Earns Overweight Rating from Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of Merck & Co., Inc. (NYSE:MRK – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $135.00 price objective on the stock. Several other equities analysts have also recently weighed in on MRK. BMO Capital Markets raised Merck & Co., Inc. […]

Leave a Reply

Your email address will not be published.

Previous post QuickLogic (NASDAQ:QUIK) PT Raised to $12.00 at Oppenheimer
Next post Getty Images (NYSE:GETY) PT Lowered to $7.00